Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- PEST Analysis
- PORTER’s Analysis
- Regulatory Scenario
- Merger, Collaboration and Acquisition Scenario
- Product Launches/Approvals
- Epidemiology
- Market Dynamics
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Acute CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Delayed CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Anticipatory nausea and emesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Breakthrough CINV/Refractory CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Drug Class, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Dopamine Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Metoclopramide
- Chlorpromazine
- Prochlorperazine
- Haloperidol
- Droperidol
- Others
- Serotonin (5-HT3) receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Ondansetron
- Granisetron
- Palonosetron
- Dolasetron
- Others
- Substance P/NK-1 Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Aprepitant
- Fosaprepitant
- Netupitant
- Others
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Dexamethasone
- Methylprednisolone
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Transdermal Patch
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel, 2021 – 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 – 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
- Overview
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region, 2021 – 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022–2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
Competitive Landscape
- Eisai Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharmanovia
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlight
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Helsinn Healthcare SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reddy’s Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Validus Pharmaceuticals LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LGM Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AdvaCare Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Norgine
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PV Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hetero Healthcare Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sino Biopharmaceutical Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Otsuka Pharmaceutical Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OPKO Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Weefsel Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rosemont Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Starton Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Co., Ltd.
Section
- Research Methodology
- About Us
*Browse 45 market data tables and 39 figures on "Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market” - forecast to 2033